PsyBio Therapeutics Files Patent Application with USPTO for Production Methods of Methylated Trypatamines and Associated Analogs Post published:August 16, 2021 Post category:Press Release
Mindset Pharma Announces Publication of Three PCT Patent Applications for Its Next Generation Psychedelic Drug Candidates Post published:August 16, 2021 Post category:Press Release
atai Life Sciences Reports Second Quarter 2021 Financial Results and Business Update Post published:August 16, 2021 Post category:Press Release
Field Trip Health Ltd. Reports Fiscal First Quarter 2022 Financial Results Post published:August 16, 2021 Post category:Press Release
Beckley Psytech completes oversubscribed $80m (£58m) fundraise to develop portfolio of psychedelic medicine breakthroughs Post published:August 16, 2021 Post category:Press Release
Psychedelic Bulletin: Compass Pathways Secures 5th Patent; atai to Develop Salvinorin A Post published:August 13, 2021 Post category:Psychedelic Bulletin
Cybin Announces Additional Adelia Milestone Achievements Post published:August 12, 2021 Post category:Press Release
Bexson Biomedical Launches New Project, Applying Subcutaneous Delivery Technology To Multiple Psychedelic Compounds For Therapeutic Use Post published:August 12, 2021 Post category:Press Release
Psilera Initiates Landmark Preclinical Studies with New Psychedelic Derivatives aimed at Reducing Alcohol Consumption Post published:August 12, 2021 Post category:Press Release
MindMed Announces 2021 Q2 Financial Results; Cash Balance of $157 USD Million ($195 CAD Million) to Execute on Diverse Clinical Pipeline Post published:August 12, 2021 Post category:Press Release